EpiVax and FDA Scientists Publish New Insights on Immunogenicity Risks of Peptide-Related Impurities in Generic Teriparatide
PROVIDENCE, R.I., Dec. 9, 2025 /PRNewswire/ -- EpiVax, Inc., with U.S. Food and Drug Administration (FDA) and CUBRC, Inc. (Buffalo, NY) scientist collaborators, announces the publication of a study titled "Immunogenicity Risk Assessment of...
Menarini Group Presents Elacestrant (ORSERDU®) Phase 2 Combination Data in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2025 San Antonio Breast Cancer Symposium
In addition, the expansive elacestrant clinical development program updates reinforce its potential as a backbone endocrine therapy in combination settings, as well as in both metastatic and early stage breast cancer. FLORENCE, Italy and NEW YORK,...
IBM to Acquire Confluent to Create Smart Data Platform for Enterprise Generative AI
$11B acquisition to deliver end-to-end data platform for businesses to connect, process and govern data for applications and AI agents Transaction expected to be accretive to adjusted EBITDA within the first full year, and free cash flow in year...
Qualcomm Highlights Edge AI Innovation at Qualcomm AI Program for Innovators (QAIPI) 2025 - APAC Demo Day and Sets the Stage for 2026
Showcasing transformative edge AI innovations across robotics, healthcare and smart city solutions SEOUL, South Korea, Dec. 8, 2025 /PRNewswire/ -- Qualcomm Technologies, Inc. hosted the Qualcomm AI Program for Innovators (QAIPI) 2025 – APAC Demo...
All Approved Indications of Five Akeso's Innovative Drugs Included in China's Latest NRDL: Featuring Two First-in-Class Bispecifics with New First-Line Indications and Three Newly Negotiated Drugs
HONG KONG, Dec. 7, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced the successful inclusion of all five of the Company's self-developed innovative drugs into the updated National Reimbursement Drug List (NRDL) for...
Innovent Announces Inclusion of Seven Innovative Drugs including TYVYT New Indication and SYCUME in China's National Reimbursement Drug List
SAN FRANCISCO and SUZHOU, China, Dec. 7, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of...
China Automotive Systems Advances High-Torque Intelligent Steering Motors to Mass Production for Commercial Vehicles
WUHAN, China, Dec. 5, 2025 /PRNewswire/ -- China Automotive Systems, Inc. (NASDAQ: CAAS) ("CAAS" or the "Company"), a leading power steering components and systems supplier in China, today announced that its subsidiary, Hyoseong (Wuhan) Motion...
Infinix Brings Tournament-Grade Performance to the 2025 PUBG MOBILE Global Championship with GT 30 Pro as the Official Gaming Device
Infinix reinforces its commitment to mobile esports worldwide as the GT 30 Pro powers the 2025 PUBG MOBILE GLOBAL CHAMPIONSHIP in Bangkok. HONG KONG, Dec. 5, 2025 /PRNewswire/ -- Infinix today announced its continued cooperation with PUBG MOBILE for...
IMAX and Wanda Film to Explore Opportunities for Joint Merchandise Development and Retail initiatives
Longstanding Strategic Partnership Expands into Consumer Products and the Growing "Lobby Economy" SHANGHAI, Dec. 5, 2025 /PRNewswire/ -- IMAX Corporation (NYSE: IMAX), IMAX China Holding, Inc. (HKEX: 1970) and Wanda Film Holding Co., Ltd. (SZSE:...
Infortrend High-Density 90-Bay Storage Helps Tackle Data Growth and Rack Constraints in Diverse Enterprise Deployments
TAIPEI, Dec. 4, 2025 /PRNewswire/ -- Infortrend Technology, Inc. (TWSE: 2495), a leading provider of enterprise storage and AI solutions, today announced the growing adoption of its EonStor GS 4U 90-bay unified storage across diverse real-world...